...
首页> 外文期刊>Current medical research and opinion >The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients.
【24h】

The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients.

机译:1998年亚洲糖尿病护理研究(Diabcare-Asia)-1型和2型糖尿病患者的控制和并发症结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to describe the glycaemic and metabolic control and diabetes-related complications in type 1 and type 2 Asian patients. METHODS: Data of diabetes patients from 230 diabetes centres in 12 Asian regions were collected on a retrospective-prospective basis through review of medical records, interview and laboratory assessments. Analysis of glycated haemoglobin (HbA1c) was carried out in central laboratories appointed by Bio-Rad. The data collection case record forms were scanned electronically. RESULTS: 22177 patients with valid data made up the analysis population. Among patents with type 1 and type 2 diabetes, there was a higher proportion of women than men (53% vs. 47% for type 1 patients and 56% vs. 44% for type 2 diabetes). Hypertension (61%) and overweight (40% with BMI > or = 25 kg/m2 were common in type 2 patients. Dyslipidaemia was also present in at least half of both types of patients. Control of glycaemia (mean HbA,1c and fasting blood glucose [FBG]) was poor in type 1 (9.9 +/- 2.5%; 10.2 +/- 5.2 mmol/l) and type 2 patients (8.5 +/- 2.0%; 8.9 +/- 3.4 mmol/l). Glycaemia in the majority of both types of patients fell short of those stipulated by various guidelines. In type 2 patients, glycaemia deteriorated (HbA1c > 7.5%, FBG > or = 7.0 mmol/l) with duration of diabetes > 7 years. Both types of diabetes appear to share a similar high prevalence of complications of cataract, retinopathy and neuropathy, although the prevalence of cataract (27%) and neuropathy (35%) was higher in type 2 diabetes. Screening for microalbuminuria was not common. CONCLUSIONS: The Inadequate metabolic and hypertension control, especially in type 2 patients, needs to be addressed.
机译:这项研究的目的是描述亚洲1型和2型患者的血糖和代谢控制以及与糖尿病相关的并发症。方法:通过回顾性回顾性基础,通过回顾病历,访谈和实验室评估,收集了来自亚洲12个地区230个糖尿病中心的糖尿病患者的数据。糖化血红蛋白(HbA1c)的分析是在Bio-Rad指定的中央实验室中进行的。数据收集案例记录表已电子扫描。结果:22177例有效数据患者构成了分析人群。在患有1型和2型糖尿病的专利中,女性的比例高于男性(53%对1型患者为47%,2型糖尿病为56%对44%)。高血压(61%)和超重(40%,BMI>或= 25 kg / m2)在2型患者中很常见。两种类型的患者中至少有一半存在血脂异常。血糖控制(平均HbA,1c和禁食) 1型(9.9 +/- 2.5%; 10.2 +/- 5.2 mmol / l)和2型患者(8.5 +/- 2.0%; 8.9 +/- 3.4 mmol / l)血糖[FBG])较差。两种类型患者中的大多数患者的血糖均未达到各种指南的规定;在2型患者中,糖尿病持续时间超过7年的患者血糖升高(HbA1c> 7.5%,FBG>或= 7.0 mmol / l)。尽管2型糖尿病的白内障(27%)和神经病变(35%)的患病率较高,但糖尿病的白内障,视网膜病变和神经病变的并发症患病率也相似,因此微量白蛋白尿的筛查并不常见。需要解决代谢和高血压控制不足的问题,尤其是在2型患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号